- Home
- BIOX vs TERN Comparison
BIOX vs TERN Comparison
Compare BIOX & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOX
- TERN
- Stock Information
- Founded
- BIOX 2001
- TERN 2017
- Country
- BIOX Argentina
- TERN United States
- Employees
- BIOX N/A
- TERN N/A
- Industry
- BIOX Agricultural Chemicals
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- BIOX Industrials
- TERN Health Care
- Exchange
- BIOX Nasdaq
- TERN Nasdaq
- Market Cap
- BIOX 275.1M
- TERN 298.1M
- IPO Year
- BIOX N/A
- TERN 2021
- Fundamental
- Price
- BIOX $4.24
- TERN $2.35
- Analyst Decision
- BIOX Strong Buy
- TERN Buy
- Analyst Count
- BIOX 4
- TERN 5
- Target Price
- BIOX $9.88
- TERN $18.38
- AVG Volume (30 Days)
- BIOX 257.9K
- TERN 1.0M
- Earning Date
- BIOX 05-12-2025
- TERN 05-12-2025
- Dividend Yield
- BIOX N/A
- TERN N/A
- EPS Growth
- BIOX N/A
- TERN N/A
- EPS
- BIOX 0.02
- TERN N/A
- Revenue
- BIOX $407,732,105.00
- TERN N/A
- Revenue This Year
- BIOX N/A
- TERN N/A
- Revenue Next Year
- BIOX $7.55
- TERN N/A
- P/E Ratio
- BIOX $190.15
- TERN N/A
- Revenue Growth
- BIOX N/A
- TERN N/A
- 52 Week Low
- BIOX $3.69
- TERN $2.32
- 52 Week High
- BIOX $13.18
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- BIOX 42.00
- TERN 24.66
- Support Level
- BIOX $4.31
- TERN $3.07
- Resistance Level
- BIOX $5.09
- TERN $3.72
- Average True Range (ATR)
- BIOX 0.37
- TERN 0.20
- MACD
- BIOX 0.03
- TERN -0.05
- Stochastic Oscillator
- BIOX 20.56
- TERN 2.22
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.